Jivan Yewle1, Paritosh Wattamwar1, Zhimin Tao2, Eric M Ostertag1, P Peter Ghoroghchian3,4,5. 1. Vindico Pharmaceuticals, Inc., A169 ASTeCC Bldg., Lexington, Kentucky, 40506, USA. 2. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building 76-261F, Cambridge, Massachusetts, 02139, USA. 3. Vindico Pharmaceuticals, Inc., A169 ASTeCC Bldg., Lexington, Kentucky, 40506, USA. ppg@mit.edu. 4. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Building 76-261F, Cambridge, Massachusetts, 02139, USA. ppg@mit.edu. 5. Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts, 02115, USA. ppg@mit.edu.
Abstract
PURPOSE: To develop a technique that maximizes the encapsulation of functional proteins within neutrally charged, fully PEGylated and nanoscale polymer vesicles (i.e., polymersomes). METHODS: Three conventional vesicle formation methods were utilized for encapsulation of myoglobin (Mb) in polymersomes of varying size, PEG length, and membrane thickness. Mb concentrations were monitored by UV-Vis spectroscopy, inductively coupled plasma optical emission spectroscopy (ICP-OES) and by the bicinchoninic acid (BCA) assay. Suspensions were subject to protease treatment to differentiate the amounts of surface-associated vs. encapsulated Mb. Polymersome sizes and morphologies were monitored by dynamic light scattering (DLS) and by cryogenic transmission electron microscopy (cryo-TEM), respectively. Binding and release of oxygen were measured using a Hemeox analyzer. RESULTS: Using the established "thin-film rehydration" and "direct hydration" methods, Mb was found to be largely surface-associated with negligible aqueous encapsulation within polymersome suspensions. Through iterative optimization, a novel "progressive saturation" technique was developed that greatly increased the final concentrations of Mb (from < 0.5 to > 2.0 mg/mL in solution), the final weight ratio of Mb-to-polymer that could be reproducibly obtained (from < 1 to > 4 w/w% Mb/polymer), as well as the overall efficiency of Mb encapsulation (from < 5 to > 90%). Stable vesicle morphologies were verified by cryo-TEM; the suspensions also displayed no signs of aggregate formation for > 2 weeks as assessed by DLS. "Progressive saturation" was further utilized for the encapsulation of a variety of other proteins, ranging in size from 17 to 450 kDa. CONCLUSIONS: Compared to established vesicle formation methods, "progressive saturation" increases the quantities of functional proteins that may be encapsulated in nanoscale polymersomes.
PURPOSE: To develop a technique that maximizes the encapsulation of functional proteins within neutrally charged, fully PEGylated and nanoscale polymer vesicles (i.e., polymersomes). METHODS: Three conventional vesicle formation methods were utilized for encapsulation of myoglobin (Mb) in polymersomes of varying size, PEG length, and membrane thickness. Mb concentrations were monitored by UV-Vis spectroscopy, inductively coupled plasma optical emission spectroscopy (ICP-OES) and by the bicinchoninic acid (BCA) assay. Suspensions were subject to protease treatment to differentiate the amounts of surface-associated vs. encapsulated Mb. Polymersome sizes and morphologies were monitored by dynamic light scattering (DLS) and by cryogenic transmission electron microscopy (cryo-TEM), respectively. Binding and release of oxygen were measured using a Hemeox analyzer. RESULTS: Using the established "thin-film rehydration" and "direct hydration" methods, Mb was found to be largely surface-associated with negligible aqueous encapsulation within polymersome suspensions. Through iterative optimization, a novel "progressive saturation" technique was developed that greatly increased the final concentrations of Mb (from < 0.5 to > 2.0 mg/mL in solution), the final weight ratio of Mb-to-polymer that could be reproducibly obtained (from < 1 to > 4 w/w% Mb/polymer), as well as the overall efficiency of Mb encapsulation (from < 5 to > 90%). Stable vesicle morphologies were verified by cryo-TEM; the suspensions also displayed no signs of aggregate formation for > 2 weeks as assessed by DLS. "Progressive saturation" was further utilized for the encapsulation of a variety of other proteins, ranging in size from 17 to 450 kDa. CONCLUSIONS: Compared to established vesicle formation methods, "progressive saturation" increases the quantities of functional proteins that may be encapsulated in nanoscale polymersomes.
Authors: Natalie A Christian; Michael C Milone; Shraddha S Ranka; Guizhi Li; Paul R Frail; Kevin P Davis; Frank S Bates; Michael J Therien; P Peter Ghoroghchian; Carl H June; Daniel A Hammer Journal: Bioconjug Chem Date: 2007 Jan-Feb Impact factor: 4.774
Authors: Chin Ken Wong; Alistair J Laos; Alexander H Soeriyadi; Jörg Wiedenmann; Paul M G Curmi; J Justin Gooding; Christopher P Marquis; Martina H Stenzel; Pall Thordarson Journal: Angew Chem Int Ed Engl Date: 2015-03-03 Impact factor: 15.336
Authors: Sophia P Wu; Intae Lee; P Peter Ghoroghchian; Paul R Frail; Gang Zheng; Jerry D Glickson; Michael J Therien Journal: Bioconjug Chem Date: 2005 May-Jun Impact factor: 4.774
Authors: P Peter Ghoroghchian; Paul R Frail; Guizhi Li; John A Zupancich; Frank S Bates; Daniel A Hammer; Michael J Therien Journal: Chem Mater Date: 2007-03-20 Impact factor: 9.811
Authors: Peter J Photos; Lucie Bacakova; Bohdana Discher; Frank S Bates; Dennis E Discher Journal: J Control Release Date: 2003-07-31 Impact factor: 9.776
Authors: Barbara Weiss; Marc Schneider; Leon Muys; Sebastian Taetz; Dirk Neumann; Ulrich F Schaefer; Claus-Michael Lehr Journal: Bioconjug Chem Date: 2007-06-23 Impact factor: 4.774
Authors: Changjin Huang; David Quinn; Yoel Sadovsky; Subra Suresh; K Jimmy Hsia Journal: Proc Natl Acad Sci U S A Date: 2017-03-06 Impact factor: 11.205